Showing results (71-80 of 110) with videos related to
Sort By:
Pageof 11
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 1, 1995
Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseasesJ Pe'er, D Shweiki, A Itin, et al.Cancer Research|June 30, 2001
Entry routes of malignant lymphoma into the brain and eyes in a mouse modelJ Hochman, N Assaf, M Deckert-Schlüter, et al.Nature Medicine|October 1, 1995
Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurityT Alon, I Hemo, A Itin, et al.Ophthalmology|March 21, 1998
Vascular endothelial growth factor upregulation in human central retinal vein occlusionJ Pe'er, R Folberg, A Itin, et al.The British Journal of Ophthalmology|March 1, 1996
Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathyJ Pe'er, R Folberg, A Itin, et al.European Journal of Ophthalmology|July 23, 1998
Ocular and orbital complications following the treatment of retinoblastomaI Anteby, N Ramu, L Gradstein, et al.Ophthalmology|August 1, 1997
Rubeosis iridis in retinoblastoma. Histologic findings and the possible role of vascular endothelial growth factor in its inductionJ Pe'er, M Neufeld, M Baras, et al.Eye (London, England)|January 1, 1997
The microcirculation of choroidal and ciliary body melanomasR Folberg, M Mehaffey, L M Gardner, et al.Ophthalmology|July 1, 1994
Mean of the ten largest nucleoli, microcirculation architecture, and prognosis of ciliochoroidal melanomasJ Pe'er, V Rummelt, L Mawn, et al.Cancer|February 19, 1999
Microsatellite instability and p53 mutations in pediatric secondary malignant neoplasmsA Gafanovich, N Ramu, S Krichevsky, et al.Pageof 11